Flibanserin Approval Not Supported by Data, Review SuggestsFlibanserin Approval Not Supported by Data, Review Suggests

The female libido drug showed a significant adverse event rate and only marginal efficacy in a new meta-analysis; experts questioned US Food and Drug Administration approval. Medscape Medical News
Source: Medscape ObGyn and Womens Health Headlines - Category: OBGYN Tags: Ob/Gyn & Women ' s Health News Source Type: news